| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | Gemcitabine | gCSI | pan-cancer | AAC | -0.22 | 9e-05 |
| mRNA | BRD-K07442505 | CTRPv2 | pan-cancer | AAC | 0.14 | 0.0001 |
| mRNA | Vorinostat | GDSC1000 | pan-cancer | AAC | -0.12 | 0.0001 |
| mRNA | I-BET151 | CTRPv2 | pan-cancer | AAC | -0.11 | 0.0004 |
| mRNA | Irinotecan | gCSI | pan-cancer | AAC | -0.18 | 0.0005 |
| mRNA | Doxorubicin | gCSI | pan-cancer | AAC | -0.18 | 0.0006 |
| mRNA | RO-3306 | GDSC1000 | pan-cancer | AAC | 0.12 | 0.0007 |
| mRNA | Vorinostat | gCSI | pan-cancer | AAC | -0.15 | 0.003 |
| mRNA | Tamoxifen | CTRPv2 | pan-cancer | AAC | 0.11 | 0.003 |
| mRNA | Imatinib | CTRPv2 | pan-cancer | AAC | 0.11 | 0.004 |